J&J wins FDA approval for facial filler

J&J received FDA approval to market Evolence, the first offering by a major U.S. pharmaceutical manufacturer in the dermal filler market. The injectable collagen, from J&J's new aesthetics group, is a porcine-derived collagen filler recommended for treating facial wrinkles, especially deep facial wrinkles and folds, and will compete with big sellers Juvaderm (Allergan) and Restalyne (Medicis). Success will likely depend on whether consumers prefer a pig-derived product or a synthetic one, as well as the likelihood of consumers to hit the luxury cosmetic bar to drown their sorrows in challenging economic times. Report


Using AI and RWD to Uncover Rare Disease Insights, Accelerate Commercialization and Improve Patient Outcomes

Wednesday, March 24 | 2pm ET / 11am PT

Learn how IPM.ai transformed real world data into real world insights to assist Audentes in their development of AT132 for the treatment of XLMTM. The session reviews how IPM.ia and Audentes collaborated to uncover the XLMTM patient population.